Ovitrelle (Choriogonadotropin Alfa)

Choriogonadotropin alfa, the active ingredient in Ovitrelle, is a gonadotropin hormone presented as a unknown/unknown for subcutaneous use. It treats infertility related disorders and is used in assisted reproductive technology cycles in women. GNH USA supplies Ovitrelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ovitrelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ovitrelle is a gonadotropin hormone that supports the final stages of the ovulatory cycle.

- Assisted reproductive technology (ART) cycles:  Provides   ​    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​ ​   ​  ​ -  Female     ​  ​  … -   …  …  …  …  …  …  -  …  …  ...

Common        

Action  

....